184 related articles for article (PubMed ID: 35902562)
21. DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
Ronchetti L; Melucci E; De Nicola F; Goeman F; Casini B; Sperati F; Pallocca M; Terrenato I; Pizzuti L; Vici P; Sergi D; Di Lauro L; Amoreo CA; Gallo E; Diodoro MG; Pescarmona E; Vitale I; Barba M; Buglioni S; Mottolese M; Fanciulli M; De Maria R; Maugeri-Saccà M
Int J Cancer; 2017 Jun; 140(11):2587-2595. PubMed ID: 28233295
[TBL] [Abstract][Full Text] [Related]
22. Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells.
Kim HJ; Min A; Im SA; Jang H; Lee KH; Lau A; Lee M; Kim S; Yang Y; Kim J; Kim TY; Oh DY; Brown J; O'Connor MJ; Bang YJ
Int J Cancer; 2017 Jan; 140(1):109-119. PubMed ID: 27501113
[TBL] [Abstract][Full Text] [Related]
23. Trim14 promotes autophagy and chemotherapy resistance of gastric cancer cells by regulating AMPK/mTOR pathway.
Xiao F; Ouyang B; Zou J; Yang Y; Yi L; Yan H
Drug Dev Res; 2020 Aug; 81(5):544-550. PubMed ID: 32096264
[TBL] [Abstract][Full Text] [Related]
24. Investigation of switch from ATM to ATR signaling at the sites of DNA damage induced by low and high LET radiation.
Saha J; Wang M; Cucinotta FA
DNA Repair (Amst); 2013 Dec; 12(12):1143-51. PubMed ID: 24238855
[TBL] [Abstract][Full Text] [Related]
25. ATR inhibition preferentially targets homologous recombination-deficient tumor cells.
Krajewska M; Fehrmann RS; Schoonen PM; Labib S; de Vries EG; Franke L; van Vugt MA
Oncogene; 2015 Jun; 34(26):3474-81. PubMed ID: 25174396
[TBL] [Abstract][Full Text] [Related]
26. Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin.
Zhao YX; Ma LB; Yang Z; Wang F; Wang HY; Dang JY
World J Gastrointest Oncol; 2023 Feb; 15(2):286-302. PubMed ID: 36908323
[TBL] [Abstract][Full Text] [Related]
27. The identification of the ATR inhibitor VE-822 as a therapeutic strategy for enhancing cisplatin chemosensitivity in esophageal squamous cell carcinoma.
Shi Q; Shen LY; Dong B; Fu H; Kang XZ; Yang YB; Dai L; Yan WP; Xiong HC; Liang Z; Chen KN
Cancer Lett; 2018 Sep; 432():56-68. PubMed ID: 29890208
[TBL] [Abstract][Full Text] [Related]
28. Decarbamoyl mitomycin C (DMC) activates p53-independent ataxia telangiectasia and rad3 related protein (ATR) chromatin eviction.
Xiao G; Kue P; Bhosle R; Bargonetti J
Cell Cycle; 2015; 14(5):744-54. PubMed ID: 25565400
[TBL] [Abstract][Full Text] [Related]
29. Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Chang W; Guan W; Liu Y; Shen Q; Yu Y; Zhang H; Cao G
Cancer; 2013 Oct; 119(19):3436-45. PubMed ID: 23821160
[TBL] [Abstract][Full Text] [Related]
30. PARP Inhibition Increases the Reliance on ATR/CHK1 Checkpoint Signaling Leading to Synthetic Lethality-An Alternative Treatment Strategy for Epithelial Ovarian Cancer Cells Independent from HR Effectiveness.
Gralewska P; Gajek A; Marczak A; Mikuła M; Ostrowski J; Śliwińska A; Rogalska A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352723
[TBL] [Abstract][Full Text] [Related]
31. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
[TBL] [Abstract][Full Text] [Related]
32. Oxidative stress activates NORAD expression by H3K27ac and promotes oxaliplatin resistance in gastric cancer by enhancing autophagy flux via targeting the miR-433-3p.
Wang J; Sun Y; Zhang X; Cai H; Zhang C; Qu H; Liu L; Zhang M; Fu J; Zhang J; Wang J; Zhang G
Cell Death Dis; 2021 Jan; 12(1):90. PubMed ID: 33462197
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneous nuclear ribonucleoprotein L facilitates recruitment of 53BP1 and BRCA1 at the DNA break sites induced by oxaliplatin in colorectal cancer.
Hu W; Lei L; Xie X; Huang L; Cui Q; Dang T; Liu GL; Li Y; Sun X; Zhou Z
Cell Death Dis; 2019 Jul; 10(8):550. PubMed ID: 31320608
[TBL] [Abstract][Full Text] [Related]
34. Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway.
Zhang JX; Xu Y; Gao Y; Chen C; Zheng ZS; Yun M; Weng HW; Xie D; Ye S
Mol Cancer; 2017 Jan; 16(1):18. PubMed ID: 28114937
[TBL] [Abstract][Full Text] [Related]
35. Loss of BRCA1 expression leads to worse survival in patients with gastric carcinoma.
Zhang ZZ; Liu YJ; Yin XL; Zhan P; Gu Y; Ni XZ
World J Gastroenterol; 2013 Mar; 19(12):1968-74. PubMed ID: 23569343
[TBL] [Abstract][Full Text] [Related]
36. JUNB mediates oxaliplatin resistance via the MAPK signaling pathway in gastric cancer by chromatin accessibility and transcriptomic analysis.
Li S; Wei Y; Sun X; Liu M; Zhu M; Yuan Y; Zhang J; Dong Y; Hu K; Ma S; Zhang X; Xu B; Jiang H; Gan L; Liu T
Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1784-1796. PubMed ID: 37337631
[TBL] [Abstract][Full Text] [Related]
37. Txr1: an important factor in oxaliplatin resistance in gastric cancer.
Bi J; Bai Z; Ma X; Song J; Guo Y; Zhao J; Yi X; Han S; Zhang Z
Med Oncol; 2014 Feb; 31(2):807. PubMed ID: 24362794
[TBL] [Abstract][Full Text] [Related]
38. The ATM and Rad3-Related (ATR) Protein Kinase Pathway Is Activated by Herpes Simplex Virus 1 and Required for Efficient Viral Replication.
Edwards TG; Bloom DC; Fisher C
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263259
[TBL] [Abstract][Full Text] [Related]
39. p21-Activated kinase 6 (PAK6) inhibits prostate cancer growth via phosphorylation of androgen receptor and tumorigenic E3 ligase murine double minute-2 (Mdm2).
Liu T; Li Y; Gu H; Zhu G; Li J; Cao L; Li F
J Biol Chem; 2013 Feb; 288(5):3359-69. PubMed ID: 23132866
[TBL] [Abstract][Full Text] [Related]
40. Circular RNA circ_0032821 contributes to oxaliplatin (OXA) resistance of gastric cancer cells by regulating SOX9 via miR-515-5p.
Zhong Y; Wang D; Ding Y; Tian G; Jiang B
Biotechnol Lett; 2021 Feb; 43(2):339-351. PubMed ID: 33123829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
